Atrial Fibrillation Clinical Trials

A listing of Atrial Fibrillation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 28 clinical trials
Featured trial
TactiCath Post Market Approval Study

The purpose of the research study is to obtain additional information safety and effectiveness of an FDA approved catheter when used to treat patients with Paroxysmal atrial fibrillation.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Featured trial
REDUCE Study: For patients with Elevated Left Atrial Pressure with Heart Failure  

This study is assessing the safety and tolerability of an interatrial septal device implanted for those who have a dilated left atrium or some degree of diastolic dysfunction. This is often known as preserved ejection fraction heart failure. This study is blinded over the course of 2 years, and there …

  • 0 views
  • 19 Feb, 2024
  • 1 location
nMARQ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation

Subjects with symptomatic PAF who have had at least one AF episode documented within one (1) year prior to enrollment and who have failed at least one antiarrhythmic drug (AAD).

  • 0 views
  • 19 Feb, 2024
  • 1 location
Medtronic Evaluation of Multi-Electrode Phased RF Technology in Persistent Atrial Fibrillation

The Medtronic Phased RF System is intended to be used for mapping intracardiac electrograms and to deliver precise, temperature controlled radio frequency (RF) ablation therapy within the left atrium of the heart for the treatment of atrial fibrillation. The Phased RF System includes the GENius Multi Channel Radio Frequency Ablation …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation

The device under study is the Blazer Open-Irrigated Catheter. The catheter is used to treat patients who have paroxysmal atrial fibrillation, and have major inclusion criteria of drug refractory, older than 18 years of age, and has at least one documented case of parox. atrial fibrillation.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Prospective Elimination Of Distal Coronary Sinus-Left Atrial Connections for Atrial Fibrillation Ablation Trial

In patients with paroxysmal or persistent atrial fibrillation, undergoing first AF ablation and age over 18 years are eligible for the study.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation with Focal Impulse and Rotor Modulation Guided Procedures

Catheter ablation at these relatively circumscribed areas can significantly affect AF, either by substantial slowing of the rate or termination (to an atrial tachycardia or sinus rhythm).

  • 0 views
  • 19 Feb, 2024
  • 1 location
Safety of Oral Anticoagulation Therapy Withdrawal after Successful Pulmonary Vein Antrum Isolation in Patients with Atrial Fibrillation and Associated High Risk Factors for Embolic Events (OAT Pilot Study)

The purpose of the study is to assess the safety of stopping oral anticoagulation therapy (OAT) in patients who have undergone a successful ablation procedure for atrial fibrillation. A successful ablation procedure for atrial fibrillation is defined by the protocol as being arrhythmia free 3 months after the procedure.

  • 0 views
  • 19 Feb, 2024
  • 1 location
A Randomized OPen-label Active controlled Multi-center Study to Evaluate the Safety of Rivaroxaban and Vitamin K Antagonists in Subjects Undergoing Catheter Ablation for Atrial Fibrillation

In order to achieve 200 per-protocol subjects, approximately 250 eligible subjects, age 18 years or older, with a history of paroxysmal or persistent NVAF who are scheduled to undergo an elective catheter ablation procedure will randomize in a 1:1 ratio to receive either rivaroxaban 20 mg orally, once-daily, preferably administered …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Utility of Esophageal Cooling Therapy for the Prevention of Thermal Injury During Atrial Fibrillation Ablation: an investigator initiated randomized blinded single center pilot study

This is a small scale pilot study to evaluate if esophageal cooling using the Attune Medical Esophageal Heat Transfer Device (EnsoETM) limits the frequency or severity of thermal injury during catheter ablation of atrial fibrillation. This prospective, randomized study will include 40 patients with symptomatic AF undergoing index PVI at …

  • 0 views
  • 19 Feb, 2024
  • 1 location